#Bioretec #Finland #Tampere #Orthopedic Implants #Dr. DiGiovanni

Bioretec Expands into Innovation with Dr. Christopher W. DiGiovanni

Bioretec Ltd., a known leader in the field of bioresorbable orthopedic implants, proudly announces the addition of Dr. Christopher W. DiGiovanni to its Scientific Advisory Board (SAB). This significant appointment aims to harness Dr. DiGiovanni's extensive experience to propel the advancement of surgical technologies in orthopedic care, specifically in foot and ankle procedures.

Dr. DiGiovanni's Impressive Background

With nearly 30 years of dedicated service in the medical field, Dr. DiGiovanni stands out as an internationally recognized surgeon specializing in foot and ankle medicine. He holds the esteemed position of Professor of Orthopaedic Surgery at Harvard Medical School and serves as Chief Emeritus of Foot and Ankle Services at Massachusetts General Hospital (MGH). Throughout his career, he has served as a Past President of both the American Orthopaedic Foot and Ankle Society and the North American Orthopaedic Foot Club.

Dr. DiGiovanni's influence in orthopedic surgery is backed by an impressive portfolio of over 250 published articles and contributions to numerous medical textbooks. He is a co-founder of the MGH Foot Ankle Research and Innovation Lab (FARIL), which has played a role in advancing surgical techniques and technologies. His insights have also benefited athletes at various competitive levels, including collegiate and Olympic circles, and he has actively consulted for leading orthopedic firms globally.

Commitment to Patient-Centric Advancements

During his announcement, Dr. DiGiovanni expressed enthusiasm about the innovative direction of Bioretec, stating, "Patient-centric advancements in orthopedic surgery continue to accelerate at a remarkable pace... Novel absorbable implants represent one of the greatest areas of technological innovation and hold a tremendous promise for patients." He highlighted Bioretec's leading position in the ongoing evolution of surgical devices with its pioneering biocompatible implants.

Role in Bioretec's Scientific Advisory Board

The SAB at Bioretec plays a crucial role in providing clinical guidance as the company progresses towards the commercialization of its advanced implant platforms, notably the Activa and RemeOs™ product lines. Dr. DiGiovanni's participation is crucial in ensuring that these innovative solutions not only meet but also exceed safety and efficacy standards while addressing real-world needs.

Timo Lehtonen, Chief Technology Officer at Bioretec, expressed gratitude for welcoming Dr. DiGiovanni aboard: "He brings unparalleled expertise in foot and ankle surgery, greatly enhancing our commitment to patient care and innovation. His leadership will be essential as we broaden the reach of our innovative implants across the United States and internationally."

About Bioretec's Innovative Technologies

Bioretec is a Finnish medical device company pioneering biodegradable orthopedic implant technologies. Their products have transformed surgical care by creating implants that enhance bone growth and accelerate the healing process post-surgery. Bioretec's Activa product line features fully bioabsorbable implants made with a unique self-reinforced PLGA polymer, designed not only for effective fixation but also for natural degradation within approximately two years, thus eliminating the need for follow-up surgeries related to implant removal.

Additionally, the RemeOs™ product line, which combines high-performance magnesium alloy and hybrid composites, represents the forefront of absorbable material technology. Innovatively designed to be absorbed and replaced by bone, these implants facilitate healing while removing the need for surgical removal. The FDA approved the RemeOs product line in March 2023, followed by CE mark certification in Europe in January 2025.

With pioneering advancements in the field of orthopedic treatment, Bioretec is dedicated to developing solutions that are not only innovative but also patient-friendly, paving the way forward for future medical breakthroughs.

For more information about Bioretec and its innovative solutions, visit bioretec.com.